Dova Pharmaceuticals, Inc. 4
4 · Dova Pharmaceuticals, Inc. · Filed Jul 7, 2017
Insider Transaction Report
Form 4
Laliberte Kevin
Sr. VP, Product Development
Transactions
- Purchase
Common Stock
2017-07-05$17.00/sh+6,200$105,400→ 6,200 total
4 · Dova Pharmaceuticals, Inc. · Filed Jul 7, 2017
Common Stock